We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ALS Community Fires Back at Cavazzoni Following Hearing on Neuro Diseases
ALS Community Fires Back at Cavazzoni Following Hearing on Neuro Diseases
The ALS community is frustrated with comments made by Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Review (CDER), during a congressional hearing last week focused on the slow pace of drug approvals for neuro drugs.